Atlas Trials

Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis

Clinical trial NCT00988247 · COMPLETED

Trial details

NCT number
NCT00988247
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Rhinitis, Allergic, Perennial
Start date
2009-10-31
Primary completion
2011-02-28
Enrollment
529

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.